5691 - 5700 of 8580 Results
Title
Year
-
RESTRICTEDTitle: Time for a New Image of Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 77Issue #: 11Start Page: 1345End Page: 1345Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2020.2412Citation Count: 29
- Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel2021RESTRICTEDTitle: Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources PanelJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 1Start Page: 102End Page: 102Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2020.3536Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573798Citation Count: 150
-
RESTRICTEDTitle: Emerging Neuroimaging Biomarkers Across Disease Stage in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 10Start Page: 1262End Page: 1262Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.1312Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017381Citation Count: 75
-
RESTRICTEDTitle: Burden of Neurological Disorders Across the US From 1990-2017Journal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 2Start Page: 165End Page: 165Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamaneurol.2020.4152Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2772579/jamaneurology_feigin_2020_oi_200081_1612851425.16285.pdfCitation Count: 314
-
RESTRICTEDTitle: Fovea and foveation in Parkinson's disease.Journal Name: Behavioral NeurosciencePublisher: American Psychological Association (APA)Vol: 127Issue #: 2Start Page: 139End Page: 150Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1037/a0031225Citation Count: 22
- Post-stroke Movement Disorders: The Clinical, Neuroanatomic, and Demographic Portrait of 284 Published Cases2018RESTRICTEDTitle: Post-stroke Movement Disorders: The Clinical, Neuroanatomic, and Demographic Portrait of 284 Published CasesJournal Name: Journal of Stroke and Cerebrovascular DiseasesPublisher: Elsevier BVVol: 27Issue #: 9Start Page: 2388End Page: 2397Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jstrokecerebrovasdis.2018.04.028Best OA location URL: https://zenodo.org/records/3873438/files/Proof_from_JSCVD-D-18-00257R1.pdfCitation Count: 65
-
RESTRICTEDTitle: Meta-analysis of amantadine efficacy for improving preclinical research reliabilityJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 10Start Page: 1555End Page: 1557Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27486Citation Count: 7
-
RESTRICTEDTitle: Low Vitamin B12 and Parkinson DiseaseJournal Name: Mayo Clinic ProceedingsPublisher: Elsevier BVVol: 94Issue #: 5Start Page: 757End Page: 762Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.mayocp.2019.01.039Best OA location URL: http://www.mayoclinicproceedings.org/article/S0025619619301776/pdfCitation Count: 18
- Independent comparison of CogState computerized testing and a standard cognitive battery with neuroimaging2014OPENTitle: Independent comparison of CogState computerized testing and a standard cognitive battery with neuroimagingJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 10Issue #: 6Start Page: 779End Page: 789Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2014.09.001Best OA location URL: http://doi.org/10.1016/j.jalz.2014.09.001Citation Count: 29
- Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulators2018OPENTitle: Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulatorsJournal Name: Molecular PsychiatryPublisher: Springer Science and Business Media LLCVol: 25Issue #: 11Start Page: 2786End Page: 2799Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41380-018-0206-2Best OA location URL: https://www.nature.com/articles/s41380-018-0206-2.pdfCitation Count: 46